Brannstrom M, Milenkovic M, Tsakos E
Reprod Med Biol. 2025; 24(1):e12636.
PMID: 39935690
PMC: 11811759.
DOI: 10.1002/rmb2.12636.
Vo P, Ng K, Schoch H, Cooper J, Vupalanchi A, Flowers M
Res Sq. 2025; .
PMID: 39866881
PMC: 11760236.
DOI: 10.21203/rs.3.rs-5760731/v1.
Burlone A, Tombelli S, Viggiano D, Borgianni S, Gonfiotti A
Int J Surg Case Rep. 2025; 127:110825.
PMID: 39793337
PMC: 11780157.
DOI: 10.1016/j.ijscr.2025.110825.
Kostun J, Mescalchin A, Pesta M, Slunecko R, Ismail K, Smoligova V
BMC Womens Health. 2025; 25(1):12.
PMID: 39780118
PMC: 11715250.
DOI: 10.1186/s12905-025-03550-4.
Li C, Han Z, Chen L, Du G, Cai R
Front Oncol. 2024; 14:1480102.
PMID: 39610926
PMC: 11602650.
DOI: 10.3389/fonc.2024.1480102.
Survival benefit of cytoreductive surgery in patients with primary stage IV endometrial cancer: a systematic review & meta-analysis.
Pham E, Horeweg N, van der Marel J, Nooij L
BJC Rep. 2024; 2(1):76.
PMID: 39516418
PMC: 11523991.
DOI: 10.1038/s44276-024-00084-4.
Identification of GPNMB in endometrial cancer based on pan-cancer analysis and in vitro validation.
Tuo X, Chen J, Hao C, Dai X, Zhu J, Tian S
Discov Oncol. 2024; 15(1):489.
PMID: 39331202
PMC: 11436576.
DOI: 10.1007/s12672-024-01382-6.
The Quality of Life after Endometrial Cancer Study: Baseline Characteristics and Patient-Reported Outcomes.
Warring S, Yost K, Cheville A, Dowdy S, Faubion S, Kumar A
Curr Oncol. 2024; 31(9):5557-5572.
PMID: 39330040
PMC: 11431380.
DOI: 10.3390/curroncol31090412.
Narrative review on the evolving role of HER2/neu targeting in uterine serous cancers.
Jayraj A, Abdul-Aziz S, Mburu A, Upadhyay A, Singh N, Ghatage P
Ann Transl Med. 2024; 12(4):69.
PMID: 39118940
PMC: 11304437.
DOI: 10.21037/atm-23-1465.
Prognostic significance of lymphovascular space invasion in early-stage low-grade endometrioid endometrial cancer: a fifteen-year retrospective Chinese cohort study.
Sun B, Zhang X, Dong Y, Li X, Yang X, Zhao L
World J Surg Oncol. 2024; 22(1):203.
PMID: 39080611
PMC: 11290096.
DOI: 10.1186/s12957-024-03483-6.
The impact of metformin on survival in diabetic endometrial cancer patients: a retrospective population-based analysis.
Drevinskaite M, Kaceniene A, Linkeviciute-Ulinskiene D, Smailyte G
J Diabetes Metab Disord. 2024; 23(1):841-847.
PMID: 38932795
PMC: 11196484.
DOI: 10.1007/s40200-023-01358-3.
A Case of Well-Differentiated Endometrial Adenocarcinoma in a Postmenopausal Woman.
Shringi Jr S, Agrawal A, Hiwale K, Gadkari P
Cureus. 2024; 16(5):e61070.
PMID: 38915993
PMC: 11196016.
DOI: 10.7759/cureus.61070.
Updated endometrial cancer FIGO staging: the role of MRI in determining newly included histopathological criteria.
Akcay A, Gultekin M, Altintas F, Peker A, Balsak S, Atasoy B
Abdom Radiol (NY). 2024; 49(10):3711-3721.
PMID: 38836884
DOI: 10.1007/s00261-024-04398-2.
Real-world prevalence of microsatellite instability testing and related status in women with advanced endometrial cancer in Europe.
Kelkar S, Prabhu V, Zhang J, Ogando Y, Roney K, Verma R
Arch Gynecol Obstet. 2024; 309(6):2833-2841.
PMID: 38634898
PMC: 11147824.
DOI: 10.1007/s00404-024-07504-3.
Prognostic value of pretreatment systemic immune-inflammation index in patients with endometrial cancer: a meta-analysis.
Ji P, He J
Biomark Med. 2024; 18(7):345-356.
PMID: 38623927
PMC: 11218804.
DOI: 10.2217/bmm-2023-0629.
Real-world treatment patterns and clinical outcomes from a retrospective chart review study of patients with recurrent or advanced endometrial cancer who progressed following prior systemic therapy in Europe.
Zhang J, Kelkar S, Prabhu V, Qiao Y, Grall V, Miles N
BMJ Open. 2024; 14(4):e079447.
PMID: 38569701
PMC: 10989146.
DOI: 10.1136/bmjopen-2023-079447.
Recent management of endometrial cancer: a narrative review of the literature.
Pados G, Zouzoulas D, Tsolakidis D
Front Med (Lausanne). 2024; 10:1244634.
PMID: 38235267
PMC: 10792696.
DOI: 10.3389/fmed.2023.1244634.
Development and validation of a nomogram based on multiple preoperative immunoinflammatory indexes for survival prediction in patients with stage IA-IB endometrial cancer.
Zhang N, Liu H, Yang J, Zhong F
Am J Transl Res. 2023; 15(10):6286-6298.
PMID: 37969209
PMC: 10641344.
Intraluminal tumor cells and prognostic accuracy of endometrial cancer stage criteria: A multi-institution study.
Felix A, Sinnott J, Cohn D, Duggan M, Havrilesky L, Olawaiye A
Gynecol Oncol. 2023; 178:130-137.
PMID: 37862792
PMC: 10842547.
DOI: 10.1016/j.ygyno.2023.10.004.
Ultrasonography, macroscopy, and frozen section: whıch is better for predicting deep myometrial invasıon in endometrial cancer?.
Ozdemir C, Telli E, Oge T, Yalcin O
Rev Assoc Med Bras (1992). 2023; 69(10):e20230333.
PMID: 37729223
PMC: 10511276.
DOI: 10.1590/1806-9282.20230333.
